OMNY Health

What OMNY Health does

OMNY Health, Inc. is an Atlanta-based, privately held healthcare data company founded in 2018 by Dr. Mitesh Rao that operates a B2B real-world evidence (RWE) data exchange platform built on de-identified, first-party EHR data contributed by health systems and specialty provider networks across all 50 U.S. states. The platform aggregates 175 million+ longitudinal patient lives, 2.7 billion+ clinical encounters, 6.5 billion+ clinical notes, and 770,000+ providers across 200+ medical specialties, and combines structured EHR fields with AI/NLP-extracted unstructured clinical notes, medical device data (UDI-linked), social determinants of health data, and specialty datasets covering oncology, ophthalmology, dermatology, gastroenterology, GLP-1/metabolic disease, and immunology.

The core product is OMNY Foundation, an EHR data platform augmented by OMNY Clinical Notes (NLP/LLM extraction of disease severity and treatment rationale), a specialty Oncology suite meeting FDA Fit-for-Purpose criteria for regulatory submissions and External Control Arms, and adjunct products for SDoH, medical device surveillance, and multimodal image-plus-notes research. The company sells primarily to four enterprise segments — life sciences companies (RWE/HEOR, commercial analytics, clinical development), MedTech manufacturers (post-market surveillance, device performance), AI/healthcare technology companies (training data for predictive models), and healthcare providers (research participation and data monetization) — through direct enterprise field sales, conference-led engagement (ISPOR, HLTH, Venture Atlanta), and marketplace distribution via Datavant Connect powered by AWS Clean Rooms.

Revenue is generated through subscription-based licensing of datasets and analytics modules plus professional services for custom RWE and HEOR analyses, with quote-based, non-publicly disclosed enterprise pricing. As of December 2022, OMNY had raised approximately $17 million in total funding, led by Chicago Pacific Founders, and the company operates without a subsequent disclosed funding round.

Name

OMNY Health

Legal name

OMNY, Inc.

Website

https://omnyhealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

OMNY Health operates a B2B real-world EHR data platform covering 175 million+ de-identified patient lives across 200+ specialties and all 50 U.S. states, selling subscription-based data licensing and NLP-powered clinical analytics to life sciences, MedTech, AI/healthcare, and provider customers.

Ownership category

akta.pro rank

Product category

Real-World Evidence Data Platform

NAICS

Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Real-world evidence data
• Electronic health records
• Clinical research analytics
• Healthcare data platform
• Life sciences intelligence

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Healthcare Data Platform Licensing: OMNY Health provides access to its real-world EHR data platform through licensing agreements with life sciences companies, MedTech firms, and healthcare organizations. Revenue is generated through subscription-based access to datasets, with pricing based on scope of data access, specialty coverage, and analytics requirements.
2. Data Analytics and Insights Services: Professional services revenue from analytical services, custom research, and evidence generation using OMNY's curated datasets. Includes dashboards, reports, and consulting for HEOR and RWE strategies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

OMNY Health operates a real-world EHR data exchange platform that aggregates de-identified structured and unstructured clinical data from U.S. health systems and specialty networks, covering 175M+ patient lives across 200+ specialties. Its flagship product, OMNY Foundation, anchors this dataset and is augmented by OMNY Clinical Notes (NLP/LLM-derived unstructured note insights), specialty-specific data suites (Oncology, GLP-1, Ophthalmology, Dermatology, GI), and solutions for External Control Arms, medical device tracking, and Social Determinants of Health. The platform serves life sciences, MedTech, AI/healthcare, and provider customers with fit-for-purpose data for regulatory submissions, HEOR/RWE studies, clinical trial design, and commercial analytics.

Product overview

OMNY Health offers a unified real-world data exchange platform that enables health systems and specialty networks to share de-identified EHR datasets with external parties at scale. The core platform, OMNY Foundation, anchors EHR data at scale covering 175M+ patients, 200+ specialties, 2.7B+ encounters, and 6.5B+ clinical notes. This is augmented by specialized products: OMNY Clinical Notes transforms unstructured physician notes into AI-ready datasets; OMNY Foundation: Oncology addresses cancer research data gaps; the GLP-1 Network supports metabolic disorder research; and specialty-specific data products cover gastroenterology, dermatology, ophthalmology, and medical devices. The platform delivers fit-for-purpose data for regulatory submissions, external control arms for clinical trials, HEOR analyses, and commercial analytics. Key capabilities include NLP-powered extraction from unstructured clinical notes, medical image processing, and integration with AWS Clean Rooms for privacy-preserving data collaboration.

Differentiator

Problem solved

Functional benefit

Brands

• OMNY Foundation: EHR data platform providing powerful insights from 100M+ patients across 200+ specialties from 6.5B+ clinical notes, covering real-world healthcare encounters and clinical data.
• OMNY Clinical Notes
• OMNY Foundation: Oncology

Products and services

• OMNY Foundation Core EHR data platform that anchors OMNY's real-world data exchange, delivering research-ready, de-identified structured and unstructured clinical data from 175M+ patients across 200+ specialties with 6.5B+ clinical notes and 2.7B+ encounters covering all 50 U.S. states. Built for life sciences, MedTech, AI/healthcare, and provider customers needing longitudinal, fit-for-purpose data for RWE, HEOR, clinical trial design, External Control Arms, and commercial analytics.
• OMNY Clinical Notes Unstructured clinical notes product that transforms 6.5B+ physician notes into AI-ready datasets via NLP/LLM models (including Gemini Flash/Pro), capturing disease severity, symptoms, treatment rationale, and validated SDoH signals that structured fields or claims data miss. Designed for life sciences, AI/healthcare, and MedTech customers building predictive models and conducting deep clinical research.
• OMNY Foundation: Oncology Specialty product suite covering over 10 million oncology patient journeys from 2017 to present across the full patient journey, providing structured EHR data, clinical notes, and diagnostic reports. Built to meet FDA Fit-for-Purpose criteria to support oncology regulatory submissions and External Control Arms in oncology clinical trials.
• OMNY Health GLP-1 Network Dynamic patient network of 600,000+ patients developed for clinical research on glucagon-like peptide-1 (GLP-1) receptor agonists. Supports new studies on use of these metabolic medications in adult and pediatric populations for life sciences customers.
• OMNY Health GI Solutions Gastroenterology-focused real-world data solutions delivered in partnership with leading U.S. gastroenterology practices, supporting research across GI conditions including IBD and treatment pattern analyses such as biologic treatment alteration reasons.
• OMNY Health Ophthalmology Data Ophthalmology-centric real-world data platform covering key populations including dry eye (296K patients), dry AMD (109K), wet AMD (31K), and diabetic retinopathy (64K). Includes de-identified retinal scan images, diagnostic reports, and provider clinical assessment measures for ophthalmology research and post-market surveillance.
• OMNY Health Dermatology Data National dermatology data repository covering 22M+ patient lives across 40 states with 47,000+ providers. Supports research across conditions including psoriasis, atopic dermatitis, and other skin-related disorders, with disease severity extraction from clinical notes.
• OMNY Health Medical Device Database Medical device data product providing precision device usage information down to the patient-encounter level. Includes Unique Device Identifier (UDI) data linked to FDA's AccessGUDID database for MedTech customers needing to track device use, trends, patient journeys, and post-market surveillance.
• OMNY Health Social Determinants Data Social Determinants of Health (SDoH) data product constructed from point-of-care documentation at the patient-encounter level, leveraging ICD-10 diagnostic codes, self-reported SDoH surveys, and NLP-derived SDoH burden estimates from unstructured clinical notes.
• OMNY Health External Control Arms Real-world data solution for building External Control Arms (ECAs) for clinical trials. Uses EHR-derived control arms to mirror traditional placebo groups, demonstrated at 18.5% PGA 0/1 response rate vs 7.2% in traditional placebo, reducing trial recruitment burdens and supporting regulatory submissions.

Quantifiable outcome

• External Control Arm demonstrated 18.5% PGA 0/1 response rate vs 7.2% in traditional placebo arm, validating RWD-based comparator approach
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

Partnerships

Eleven partnerships are on record, tiered strategic, core and minor.

• Scipher MedicinestrategicStrategic or Co-development Partner · 9 January 2025Partnership integrating Scipher's PrismRA Test transcriptome genomic data into OMNY's EMR network to revolutionize autoimmune disease treatment with clinico-transcriptomics data.
• DatavantcoreTechnology or Integration · 14 June 2023Alliance to accelerate delivery of real-world data between healthcare stakeholders to enhance clinical research and drug development. OMNY became the first EHR dataset available on Datavant Connect powered by AWS Clean Rooms.
• Atropos HealthstrategicTechnology or Integration · 1 March 2023Atropos Health expanded its evidence network by partnering with OMNY Health to enhance real-world evidence generation capabilities.
• US EyestrategicStrategic or Co-development Partner · 10 May 2022Partnership for ophthalmology-centric real-world data platform. US Eye leverages OMNY's platform for data-driven decisions and clinical research opportunities.
• American Vision PartnersstrategicStrategic or Co-development Partner · 10 May 2022Partnership to gain visibility into additional clinical research opportunities and improve patient care outcomes in ophthalmology.
• Sight Growth PartnersstrategicStrategic or Co-development Partner · 10 May 2022Partnership with Sight Growth Partners as administrative services provider for ophthalmology practices to leverage data for patient care improvement.
• U.S. Department of Health and Human Services (HHS)strategicStrategic or Co-development Partner · 1 December 2021OMNY selected for 2022 PandemicX Cohort working with HHS to use data to address health equity problems brought to light by the pandemic.
• Mass Challenge Health TechstrategicStrategic or Co-development Partner · 1 December 2021Partner in PandemicX accelerator cohort to address COVID-19 health disparities through healthcare innovation.
• Sensyne HealthstrategicStrategic or Co-development Partner · 1 October 2021Teaming agreement to support breakthrough research through the power of real-world data and AI. Combined Sensyne's clinical AI with OMNY's data ecosystem.
• BTGstrategicStrategic or Co-development Partner · 1 August 2020Partnership to improve treatment for snake bite victims. OMNY platform provides near real-time CroFab antivenom stock level data to BTG and Rocky Mountain Poison & Drug Center.
• HealthTech ArkansasminorStrategic or Co-development PartnerSelected as one of six startups in HealthTech Arkansas cohort 2 to support healthcare innovation in Arkansas.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Oracle Health (Cerner): Major EHR vendor with the Cerner Real-World Data offering for clinical research — broad incumbent overlapping with OMNY's EHR-derived real-world data positioning.
• Optum (UnitedHealth Group): Operates one of the largest U.S. claims + EHR-linked data assets and sells RWE/analytics to pharma — broad incumbent overlapping with OMNY's life sciences and provider segments.
• IQVIA: Largest global RWE/RWD provider, combining claims data, EHR partnerships, and analytics for pharma — broad incumbent competing with OMNY across life sciences RWE, HEOR, and clinical development.

Direct peers

• Flatiron Health: Acquired by Roche in 2018, Flatiron aggregates de-identified EHR data from oncology practices and partners with life sciences companies on real-world evidence and regulatory submissions — directly comparable to OMNY's oncology suite and ECA capability.
• Health Catalyst: Healthcare data and analytics platform serving health systems and life sciences — comparable in serving provider data-monetization and pharma RWE/HEOR workflows.
• Atropos Health: Evidence-generation platform that turns clinical data into real-world studies; partnered with OMNY and competes in the same evidence-network category for life sciences RWE customers.
• ConcertAI: Specializes in oncology real-world data and AI-driven evidence generation for pharma and providers — overlapping with OMNY's oncology product suite and life sciences RWE/HEOR use cases.
• Tempus: Combines multimodal clinical and molecular data (EHR, imaging, genomic) for precision medicine, AI training data, and pharma partnerships — closely comparable to OMNY's AI/Healthcare customer segment and multi-modal EHR offerings.
• Veradigm: Combines ambulatory EHR (formerly Allscripts) with de-identified clinical data assets for life sciences research — comparable provider-EHR data licensing model targeting pharma RWE.

Others

• Datavant: Healthcare data connectivity / tokenization layer that powers Datavant Connect (where OMNY is the first EHR dataset) — direct ecosystem partner and partial competitor in data collaboration infrastructure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/omnyhealth
• Xx.com/OmnyHealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds3 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OMNY Health